Norway· NO-ID_34928019-1081-4071-BDD9-20280C569091
Alphagan
A brimonidine product containing brimonidine tartrate, registered in Norway by AbbVie AS. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Brimonidine is registered in 12 of 19 countries.
Countries holding a registration under ATC S01EA05 (brimonidine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Brimonidine · ATC S01EA05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Brimonidine Tartrate
- Manufacturer
- AbbVie AS
- Country
- Norway (NO)
- ATC code
- S01EA05
- ATC class
- Brimonidine
- Defined daily dose
- 0.2 ml, AT
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_34928019-1081-4071-BDD9-20280C569091
- no_varenummer1746643 x 5NOK 272.7
- gtin5016007207408
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
567 interactions on record for brimonidine.
Graded by severity as the source publishes them — 387 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Brimonidine · interactions on record
567 records
- 387 moderate
- 180 info
Most severe, free to view
- PapaverineA03AD01moderate
- MetoclopramideA03FA01moderate
- DimenhydrinatA04AB02moderate
- ThiethylperazinA04AB03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Brimonidine in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALPHAGANAbbVie s.r.o., Praha
- FranceALPHAGAN 0,2 % (2mg/ml), collyre en solutionABBVIE
- PolandAlphaganAbbVie Sp. z o.o.
- NetherlandsAlphagan 0,2% g/v (2 mg/ml) oogdruppels, oplossingAbbVie B.V.
- SwedenAlphagan 0,2 % (2 mg/ml) Ögondroppar, lösningAbbVie AB
- United StatesBrimonidine tartrateMicro Labs Limited
- FinlandBrimonidin SandozSandoz A/S
- IrelandAlphagan 0.2% w/v (2 mg/ml) eye drops, solutionIMED Healthcare Ltd.,
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Alpha-Vision Sine, Alphagan
- Belgium · Alphagan, Lumobry
- Bulgaria · Brimogen, Бримонидин Абр
- Cyprus · Brimontal, Corneax
- Czechia · Alphagan, Brimonidin Olikla
- Germany · Alphagan, Brimo-Vision
- Denmark · Alphagan, Brimonidintartrat 1a Farma
- Spain · Abradel, Alphagan
- Finland · Alphagan, Lumobry
- France · Alphagan, Brimazed
- United Kingdom (Northern Ireland) · Alphagan, Brimonidine Omnivision
- Greece · Alphagan, Brimofree
- Croatia · Alphagan, Bimanox
- Hungary · Brimogen, Lumobry
- Ireland · Alphagan, Lumobry
- Iceland · Alphagan, Brimonidin Bluefish
- Italy · Alphagan, Brimofree
- Liechtenstein · Mirvaso
- Lithuania · Brimonal, Brimonidine Tartrate Elvim
- Luxembourg · Alphagan, Brimonidin Micro Labs
- Latvia · Briglafre, Brimonal
- Malta · Alphagan, Brimogan
- Netherlands · Alphagan, Brimonidine Stulln
- Poland · Alphagan, Biprolast
- Portugal · Alphagan, Bglau
- Romania · Brimonal 2 Mg/Ml, Brimonidină Rompharm
- Sweden · Alphagan, Brimonidin Bluefish
- Slovenia · Bimanox, Luvify
- Slovakia · Brimonal, Brimonidin Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9bcacd72-d1f4-4f2c-8ba9-95744cf74c75 GET /v1/drugs/9bcacd72-d1f4-4f2c-8ba9-95744cf74c75?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øyedråper, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Brimonidin",
"merkevare_id": "ID_34928019-1081-4071-BDD9-20280C569091",
"name_form_strength": "Alphagan øyedr, oppl 2 mg/ml",
"prescription_group": "C"
}See everything about brimonidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.